Steve E. Krognes - Net Worth and Insider Trading
Steve E. Krognes Net Worth
The estimated net worth of Steve E. Krognes is at least $20 Million dollars as of 2024-07-16. Steve E. Krognes is the Director of Denali Therapeutics Inc and owns about 872,620 shares of Denali Therapeutics Inc (DNLI) stock worth over $20 Million. Details can be seen in Steve E. Krognes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steve E. Krognes has not made any transactions after 2024-07-01 and currently still holds the listed stock(s).
Transaction Summary of Steve E. Krognes
Steve E. Krognes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steve E. Krognes owns 4 companies in total, including Denali Therapeutics Inc (DNLI) , Gritstone Bio Inc (GRTS) , and Corvus Pharmaceuticals Inc (CRVS) among others .
Click here to see the complete history of Steve E. Krognes’s form 4 insider trades.
Insider Ownership Summary of Steve E. Krognes
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DNLI | Denali Therapeutics Inc | 2024-07-01 | CFO and Treasurer |
GRTS | Gritstone Bio Inc | 2023-06-16 | director |
CRVS | Corvus Pharmaceuticals Inc | 2017-06-08 | director |
2022-06-30 | director |
Steve E. Krognes Latest Holdings Summary
Steve E. Krognes currently owns a total of 1 stock. Steve E. Krognes owns 872,620 shares of Denali Therapeutics Inc (DNLI) as of July 1, 2024, with a value of $20 Million.
Latest Holdings of Steve E. Krognes
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DNLI | Denali Therapeutics Inc | 2024-07-01 | 872,620 | 23.49 | 20,497,844 |
Holding Weightings of Steve E. Krognes
Steve E. Krognes Form 4 Trading Tracker
According to the SEC Form 4 filings, Steve E. Krognes has made a total of 19 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 30,688 shares on July 1, 2024, which brought Steve E. Krognes around $678,512.
Insider Trading History of Steve E. Krognes
- 1
Steve E. Krognes Trading Performance
Steve E. Krognes Ownership Network
Ownership Network List of Steve E. Krognes
Ownership Network Relation of Steve E. Krognes
Steve E. Krognes Owned Company Details
What does Denali Therapeutics Inc do?
Who are the key executives at Denali Therapeutics Inc?
Steve E. Krognes is the CFO and Treasurer of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include COO and Secretary Alexander O. Schuth , Chief Medical Officer Carole Ho , and director & President and CEO Ryan J. Watts .
Denali Therapeutics Inc (DNLI) Insider Trades Summary
Over the past 18 months, Steve E. Krognes made 7 insider transaction in Denali Therapeutics Inc (DNLI) with a net sale of 134,061. Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 98,161 shares made by Alexander O. Schuth , a net sale of 21,406 shares made by Vicki L Sato , and a net sale of 176,973 shares made by Ryan J. Watts .
In summary, during the past 3 months, insiders sold 35,226 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 35,226 shares. During the past 18 months, 466,400 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 466,400 shares.
Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Denali Therapeutics Inc Insider Transactions
Steve E. Krognes Mailing Address
Above is the net worth, insider trading, and ownership report for Steve E. Krognes. You might contact Steve E. Krognes via mailing address: 863 Mitten Road, Suite 102, Burlingame Ca 94010.